Rothschild Investment LLC’s SpringWorks Therapeutics SWTX Stock Holding History

Rothschild Investment LLC’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-130	Closed	-$6.11K	–	3243
2025 Q2	$6.11K	Buy	130 +20	+18%	+$890	﹤0.01%	1408
2025 Q1	$4.85K	Buy	110 +15	+16%	+$690	﹤0.01%	1448
2024 Q4	$3.43K	Buy	95 +35	+58%	+$1.22K	﹤0.01%	1504
2024 Q3	$1.92K	Buy	60 +50	+500%	+$1.87K	﹤0.01%	1746
2024 Q2	$377	Buy	10 +5	+100%	+$210	﹤0.01%	2184
2024 Q1	$246	Buy	+5	New	+$231	﹤0.01%	1659

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rothschild Investment LLC's SWTX Position: Q3 2025 in Review

Rothschild Investment LLC sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 130 shares — an estimated $6.11K sold.

Rothschild Investment LLC first reported a position in SWTX in Q1 2024 and held it in 6 quarters. The position peaked at $6.11K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Rothschild Investment LLC reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Rothschild Investment LLC sold 130 SpringWorks Therapeutics shares in Q3 2025, an estimated $6.11K.
Rothschild Investment LLC first reported a position in SpringWorks Therapeutics in Q1 2024 and held it in 6 quarters.
Rothschild Investment LLC's SpringWorks Therapeutics position peaked at $6.11K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Rothschild Investment LLC's 13F filing for Q3 2025, filed 7 Nov 2025.